Table 4

Percentage of study participants “eligible for tamoxifen therapy”a by the NSABP adaptation of the Gail model

Study populationN in studyPercentage high riska,b
General sample31732.8
African-American273.7
Lesbians6518.5
Ashkenazi Jews8231.7
Total49129.1
  • a Defined as a 5-year risk of developing breast cancer of 1.7% or more.

  • b Test for equality of means, P = 0.002.